News

More U.S. Teens Are Now Taking Wegovy for Weight Loss
THURSDAY, June 5, 2025 (HealthDay News) — More American teenagers now use the weight-loss drug Wegovy, as doctors and ...
Ozempic vs. Zepbound: Which Is Better For Weight Loss?
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
Eli Lilly: If You Don't Buy On Weight Loss Promise Now, You Probably Never Will
Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...
Indianapolis Business Journal1d
Lilly says weight loss pill has vast opportunity
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...
Should You Invest $1,000 in Eli Lilly today?
Eli Lilly is a pharma player, but it offers the growth of a tech stock thanks to its weight loss drugs portfolio. The weight ...
Novo’s Ozempic linked to rare cases of serious eye disorder, EU regulator says
This is the first time a regulator has confirmed the side effect. Read more at straitstimes.com. Read more at straitstimes.com.
Agency warns that weight-loss drugs can decrease effectiveness of birth control pills
Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...
Tell us: How are you planning to afford GLP-1 drugs?
Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...
Novo Nordisk Stock: Is It Still a Smart Buy?
This one-time weight-loss drug leader has suffered several setbacks lately. It isn't wise to count out this veteran ...
Weight-loss drug Wegovy use is up 50% among U.S. teens, study shows
A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.